专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

41. 发明申请

WO2012114087A1 PARTICLE DETECTION THROUGH CHRONOAMPEROMETRIC PROFILING 审中-公开
标题翻译：通过CHRONOAMPEROMETRIC轮廓的颗粒检测
公开(公告)号：WO2012114087A1
公开(公告)日：2012-08-30
申请号：PCT/GB2012/050371
申请日：2012-02-20
申请人： ISIS INNOVATION LIMITED , COMPTON, Richard Guy , REES, Neil Vaughan , ZHOU, Yi-Ge
发明人： COMPTON, Richard Guy , REES, Neil Vaughan , ZHOU, Yi-Ge
IPC分类号： G01N27/42 , G01N15/10
CPC分类号： G01N27/49 , G01N33/18
摘要： The present invention relates to a method of detecting (or identifying) particle(s) in a sample, particularly nanoparticles which, on entering the natural environment, may pose a public health risk. The method generally involves assessing the presence and/or properties of the particles in a sample from electrochemical responses yielded by the oxidative (or reductive) consumption/destruction of particles as they collide with a working electrode. In particular, the present invention allows identifying, quantifying, and characterising of particles in a sample via the electro-oxidation of particles which collide with working electrodes operating at a suitable potential difference.
摘要翻译：本发明涉及一种检测（或识别）样品中的颗粒的方法，特别是在进入自然环境时可能引起公众健康风险的纳米颗粒。该方法通常包括评估样品中颗粒的存在和/或性质，所述电化学响应是当颗粒与工作电极碰撞时的氧化（或还原）消耗/破坏产生的。特别地，本发明允许通过与以合适的电位差工作的工作电极碰撞的颗粒的电氧化来鉴定，定量和表征样品中的颗粒。

42. 发明申请

WO2008137126A2 COMBINATION THERAPY FOR THE TREATMENT OF HCV INFECTION 审中-公开
标题翻译：用于治疗HCV感染的联合治疗
公开(公告)号：WO2008137126A2
公开(公告)日：2008-11-13
申请号：PCT/US2008/005758
申请日：2008-05-05
申请人： VERTEX PHARMACEUTICALS INCORPORATED , KWONG, Ann , MANI, Nagraj , ZHOU, Yi , LIN, Chao
发明人： KWONG, Ann , MANI, Nagraj , ZHOU, Yi , LIN, Chao
IPC分类号： A61K45/06 , A61K31/7068 , A61P31/12
CPC分类号： A61K31/497 , A61K31/7068 , A61K45/06 , A61K2300/00
摘要： The present invention relates to therapeutic combinations comprising a protease inhibitor and a polymerase inhibitor for the treatment of HCV. The present invention also relates to therapeutic combinations comprising VX-950 and a polymerase inhibitor. Also within the scope of the invention are methods using the therapeutic combinations of the present invention for treating HCV infection or alleviating one or more symptoms thereof in a patient. The present invention also provides kits comprising the combinations of the present invention.
摘要翻译：本发明涉及包含用于治疗HCV的蛋白酶抑制剂和聚合酶抑制剂的治疗组合。本发明还涉及包含VX-950和聚合酶抑制剂的治疗组合。也在本发明的范围内的方法是使用本发明的治疗组合治疗HCV感染或减轻患者中的一种或多种症状的方法。本发明还提供包含本发明组合的试剂盒。

43. 发明申请

WO2006121767A2 4-AMINOQUINOLINE COMPOUNDS FOR TREATING VIRUS-RELATED CONDITIONS 审中-公开
标题翻译：用于治疗病毒相关条件的4-氨基喹啉化合物
公开(公告)号：WO2006121767A2
公开(公告)日：2006-11-16
申请号：PCT/US2006/017200
申请日：2006-05-04
申请人： APATH, LLC , OLIVO, Paul, D. , BUSCHER, Benjamin, A. , DYALL, Julie , JOCKET-BALSAROTTI, Jennifer, I , O'GUIN, Andrew, K. , ROTH, Robert, M. , ZHOU, Yi , FRANKLIN, Gary, W. , STARKEY, Gale, W.
发明人： OLIVO, Paul, D. , BUSCHER, Benjamin, A. , DYALL, Julie , JOCKET-BALSAROTTI, Jennifer, I , O'GUIN, Andrew, K. , ROTH, Robert, M. , ZHOU, Yi , FRANKLIN, Gary, W. , STARKEY, Gale, W.
IPC分类号： A61F2/02
CPC分类号： A61K31/4706 , Y02A50/463
摘要： This invention is directed to aminoquinoline compounds, pharmaceutical compositions of such compounds, kits comprising such compounds, and uses of such compounds for preparing medicaments and treating virus-related conditions in animals.
摘要翻译：本发明涉及氨基喹啉化合物，这种化合物的药物组合物，包含这些化合物的试剂盒，以及这些化合物用于制备药物和治疗动物病毒相关病症的用途。

44. 发明申请

WO2005052681A2 A COPLANAR WAVEGUIDE LINE 审中-公开
标题翻译： COPLANAR WAVEGUIDE系列
公开(公告)号：WO2005052681A2
公开(公告)日：2005-06-09
申请号：PCT/GB2004/004515
申请日：2004-10-27
申请人： FILTRONIC PLC , KUVER, Atul , ZHOU, Yi
发明人： KUVER, Atul , ZHOU, Yi
IPC分类号： G02F1/225
CPC分类号： G02F1/2257 , G02F1/2255
摘要： A coplanar waveguide line comprising a substrate; a central electrode strip on the substrate; first and second electrode strips disposed on opposite sides of the central electrode strip and extending parallel thereto; first and second optical waveguides on the substrate, the optical waveguides being positioned between the first and central electrode strips and extending parallel thereto; the central electrode comprising at least one T-rail extending proximate to the first optical waveguide; the first electrode comprising at least one T-rail extending proximate to the second optical waveguide; the substrate comprising an n + electrically conducting layer extending between the optical waveguides; wherein the coplanar waveguide line further comprises an electrical connection between first and second electrode strips.
摘要翻译：包括衬底的共面波导线; 基板上的中心电极条; 第一电极带和第二电极带，所述第一电极带和所述第二电极带设置在所述中央电极带的相对侧上并且与其平行地延伸在基片上的第一和第二光波导，光波导位于第一和中心电极条之间并与其平行延伸; 中心电极包括至少一个靠近第一光波导延伸的T形轨道; 所述第一电极包括靠近所述第二光学波导延伸的至少一个T形轨道; 衬底包括在光波导之间延伸的n + +导电层; 其中共面波导线还包括第一和第二电极条之间的电连接。

45. 发明申请

WO2015168857A1 CAPACITIVE TOUCH SENSOR AND METHOD 审中-公开
标题翻译：电容触摸传感器和方法
公开(公告)号：WO2015168857A1
公开(公告)日：2015-11-12
申请号：PCT/CN2014/076848
申请日：2014-05-06
申请人： TEXAS INSTRUMENTS INCORPORATED , ZHANG, Jun , SHEN, Ge , XU, Kangcheng , ZHOU, Yi , MENG, Hao , JI, Rujun
发明人： ZHANG, Jun , SHEN, Ge , XU, Kangcheng , ZHOU, Yi , MENG, Hao , JI, Rujun
IPC分类号： G06F3/044
CPC分类号： G06F3/044 , H03K17/9622 , H03K2017/9613 , H03K2217/96066
摘要： A capacitive touch sensor (600) is disclosed for use with input signal. The capacitive touch sensor (600) includes a number n of input/output lines (602, 604, 606, 608, 610, 612, 614, and 616). Each of the number n of input/output lines(602, 604, 606, 608, 610, 612, 614, and 616) is electrically disconnected from every other of the number n of input/output lines. Each of the number n of input/output lines (602, 604, 606, 608, 610, 612, 614, and 616) is arranged to cross every other of the number n of input/output lines. Each of a number β of positions (618), includes one of the number n of input/output lines crossing another of the number n of input/output lines.
摘要翻译：公开了与输入信号一起使用的电容式触摸传感器（600）。电容式触摸传感器（600）包括数量为n的输入/输出线（602,604,606,608,610,612,614和616）。 n个输入/输出线（602,604,606,608,610,612,614和616）中的每一个与n个输入/输出线中的每一个电气断开。 n个输入/输出线（602,604,606,608,610,612,614和616）中的每一个被布置成与n个输入/输出线中的每一个相交。位置（618）的数量β中的每一个包括与n个输入/输出线中的另一个的输入/输出线数量n中的一个。

46. 发明申请

WO2010090857A8 METHODS FOR AMPLIFYING HEPATITIS C VIRUS NUCLEIC ACIDS 审中-公开
标题翻译：用于放大丙型肝炎病毒核酸的方法
公开(公告)号：WO2010090857A8
公开(公告)日：2012-06-28
申请号：PCT/US2010021589
申请日：2010-01-21
申请人： VERTEX PHARMA , KWONG ANN D , FRANTZ JAMES DANIEL , BARTELS DOUGLAS J , LIN CHAO , SHAMES BENJAMIN , SEEPERSAUD SHEILA , LIPPKE JUDITH A , KIEFFER TARA L , ZHOU YI , ZHANG EILEEN Z , SULLIVAN JAMES C
发明人： KWONG ANN D , FRANTZ JAMES DANIEL , BARTELS DOUGLAS J , LIN CHAO , SHAMES BENJAMIN , SEEPERSAUD SHEILA , LIPPKE JUDITH A , KIEFFER TARA L , ZHOU YI , ZHANG EILEEN Z , SULLIVAN JAMES C
IPC分类号： C12Q1/68
CPC分类号： C12Q1/707 , C12Q1/6883
摘要： A method of amplifying an HCV nucleic acid in an HCV infected sample comprises amplifying a segment of a DNA template that is complementary to a genome of HCV RNA from the sample by a two-stage PCR, wherein a first stage PCR employs a first outer primer and a second outer primer, and a second stage PCR employs a first inner primer and a second inner primer. The nucleotide sequence of the first outer primer comprises a nucleotide sequence as set forth in SEQ ID NO: 2; or SEQ ID NO:9, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 9. The nucleotide sequence of the second outer primer comprises a nucleotide sequence set forth in SEQ ID NO: 3 or 4; or a nucleotide sequence as set forth in SEQ ID NO: 10 or 11, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 10 and 11. The nucleotide sequence of the first inner primer comprises a nucleotide sequence as set forth in SEQ ID NO: 5; or SEQ ID NO: 12, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 12. The nucleotide sequence of the second inner primer comprises a nucleotide sequence as set forth in SEQ ID NO: 6 or 7; or a nucleotide sequence as set forth in SEQ ID NO: 13 or 14, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 13 and 14.
摘要翻译：在HCV感染样品中扩增HCV核酸的方法包括通过两阶段PCR从样品中扩增与HCV RNA基因组互补的DNA模板的片段，其中第一阶段PCR使用第一外部引物和第二外引物，第二阶段PCR采用第一内引物和第二内引物。第一外引物的核苷酸序列包含SEQ ID NO：2所示的核苷酸序列; 或SEQ ID NO：9，其中任选地1,2或3个核苷酸是比SEQ ID NO：9的核苷酸更多的核苷酸。第二外部引物的核苷酸序列包含SEQ ID NO：3或4所示的核苷酸序列; 或如SEQ ID NO：10或11所示的核苷酸序列，其中任选1,2或3个核苷酸是与SEQ ID NO：10和11相同的其它核苷酸。第一内引物的核苷酸序列包含核苷酸序列如SEQ ID NO：5所示; 或SEQ ID NO：12，其中任选地1,2或3个核苷酸是与SEQ ID NO：12相同的其它核苷酸。第二内引物的核苷酸序列包含SEQ ID NO：6或7所示的核苷酸序列 ; 或如SEQ ID NO：13或14所示的核苷酸序列，其中任选地1,2或3个核苷酸是与SEQ ID NO：13和14相同的其它核苷酸。

47. 发明申请

WO2008137126A3 COMBINATION THERAPY FOR THE TREATMENT OF HCV INFECTION 审中-公开
标题翻译：用于治疗HCV感染的联合治疗
公开(公告)号：WO2008137126A3
公开(公告)日：2009-04-09
申请号：PCT/US2008005758
申请日：2008-05-05
申请人： VERTEX PHARMA , KWONG ANN , MANI NAGRAJ , ZHOU YI , LIN CHAO
发明人： KWONG ANN , MANI NAGRAJ , ZHOU YI , LIN CHAO
IPC分类号： A61K45/06 , A61K31/7068 , A61P31/12
CPC分类号： A61K31/497 , A61K31/7068 , A61K45/06 , A61K2300/00
摘要： The present invention relates to therapeutic combinations comprising a protease inhibitor and a polymerase inhibitor for the treatment of HCV. The present invention also relates to therapeutic combinations comprising VX-950 and a polymerase inhibitor. Also within the scope of the invention are methods using the therapeutic combinations of the present invention for treating HCV infection or alleviating one or more symptoms thereof in a patient. The present invention also provides kits comprising the combinations of the present invention.
摘要翻译：本发明涉及包含用于治疗HCV的蛋白酶抑制剂和聚合酶抑制剂的治疗组合。本发明还涉及包含VX-950和聚合酶抑制剂的治疗组合。也在本发明的范围内的方法是使用本发明的治疗组合治疗HCV感染或减轻患者中的一种或多种症状的方法。本发明还提供包含本发明组合的试剂盒。

48. 发明申请

WO2008020404A3 METHOD FOR REDUCING SYSTEM SIGNALLING INTERCHANGING PROCESSES FOR MULTIMEDIA SUBSYSTEM 审中-公开
标题翻译：一种减少多媒体子系统信号交互过程的方法
公开(公告)号：WO2008020404A3
公开(公告)日：2008-05-15
申请号：PCT/IB2007053241
申请日：2007-08-14
申请人： UTSTARCOM TELECOM CO LTD , ZHOU YI
发明人： ZHOU YI
IPC分类号： H04Q7/00
CPC分类号： H04L65/1016
摘要： The invention provides a method of signalling interchange in IMS, able to reduce the number of the signalling interchange and improve system stability. In the signalling interchange among a network element, SLF and HSS, the method comprises sequentially the following steps: the network element receiving a message containing a user ID; according to the user ID, the network element querying in its buffer storage HSS information corresponding to the user ID; and the network element building signalling interchange with a home HSS determined by the HSS information. Thus, by adding the buffer storage to network element, the method reduces the interchanging process that I-CSCF queries SLF about the subscriber's home HSS. Therefore, the method reduces performance loss due to the number of IMS signalling interchange and improves system stability without changing the existing IMS network infrastructure and influencing the IMS session and service processing mechanism.
摘要翻译：本发明提供了一种IMS中信令交互的方法，能够减少信令交换次数，提高系统稳定性。在网元，SLF和HSS之间的信令交换中，该方法依次包括以下步骤：网元接收包含用户标识的消息; 根据所述用户标识，所述网元向其缓存HSS中查询所述用户标识对应的信息; 并且网元建立信令与由HSS信息确定的归属HSS进行交换。因此，通过将缓冲存储添加到网元，该方法减少了I-CSCF查询关于订户的归属HSS的SLF的交换过程。因此，该方法降低了由于IMS信令交换数量造成的性能损失，并且在不改变现有IMS网络基础设施并影响IMS会话和业务处理机制的情况下提高了系统稳定性。

49. 发明申请

WO2006121767A3 4-AMINOQUINOLINE COMPOUNDS FOR TREATING VIRUS-RELATED CONDITIONS 审中-公开
标题翻译：用于治疗病毒相关条件的4-氨基喹啉化合物
公开(公告)号：WO2006121767A3
公开(公告)日：2007-11-08
申请号：PCT/US2006017200
申请日：2006-05-04
申请人： APATH LLC , OLIVO PAUL D , BUSCHER BENJAMIN A , DYALL JULIE , JOCKET-BALSAROTTI JENNIFER I , O'GUIN ANDREW K , ROTH ROBERT M , ZHOU YI , FRANKLIN GARY W , STARKEY GALE W
发明人： OLIVO PAUL D , BUSCHER BENJAMIN A , DYALL JULIE , JOCKET-BALSAROTTI JENNIFER I , O'GUIN ANDREW K , ROTH ROBERT M , ZHOU YI , FRANKLIN GARY W , STARKEY GALE W
IPC分类号： A61K31/4706
CPC分类号： A61K31/4706
摘要： This invention is directed to aminoquinoline compounds, pharmaceutical compositions of such compounds, kits comprising such compounds, and uses of such compounds for preparing medicaments and treating virus-related conditions in animals.
摘要翻译：本发明涉及氨基喹啉化合物，这种化合物的药物组合物，包含这些化合物的试剂盒，以及这些化合物用于制备药物和治疗动物病毒相关病症的用途。

50. 外观设计

USD933595S1 Headphone charging case 有权
公开(公告)号：USD933595S1
公开(公告)日：2021-10-19
申请号：US29714161
申请日：2019-11-21
申请人： Sihua Geng , Zhou Yi , Jianfei Liu , Sen Wang
设计人： Sihua Geng , Zhou Yi , Jianfei Liu , Sen Wang

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式